• English
  • 舊版回顧
  • 教職工
  • 學(xué)校主頁
  • 加入收藏
艾可龍教授
發(fā)布時間:2025/09/11   閱讀量:

艾可龍

中南大學(xué)湘雅藥學(xué)院教授,藥理系主任,臨床藥學(xué)研究與轉(zhuǎn)化中心副主任,博士生導(dǎo)師,連續(xù)三年入選“全球頂尖前10萬名科學(xué)家”榜單,全球前2%頂尖科學(xué)家榜單,湖南省杰出青年基金獲得者,中國科學(xué)院青年創(chuàng)新促進(jìn)會會員、優(yōu)秀會員,心血管研究湖南省重點實驗室成員, 中國藥理學(xué)會臨床藥學(xué)專業(yè)委員會常務(wù)委員。近年來在心血管修復(fù)等領(lǐng)域取得了多項創(chuàng)新成果,以一作或通訊作者身份發(fā)表包括在Adv. Mater.IF=32.0867篇)Molecular Cancer (IF=33.92)Bioactive MaterialsIF=20.3, 8篇)、Nat. Commun. (IF=16.63篇)J. Am. Chem. Soc.IF=16.3833篇)Angew. Chem. Int. EdIF=16.8232篇)Exploration (IF=22.5) Adv. Funct. Mater.IF=19.924, 2篇Adv. Sci.IF=17.5217篇)ACS Nano (IF=15.8) 等國際權(quán)威學(xué)術(shù)期刊上72篇,文他引>19000次,H-因子為55。相關(guān)研究成果多次被 Nature NanotechnologyNature Chemistry等作為研究亮點報道。擔(dān)任20余個國際主要學(xué)術(shù)期刊審稿人,4SCI期刊的編委或青年編委成員。申請發(fā)明專利20余項,其中12項已獲授權(quán)。獲省部級一等獎2項,二等獎1項。

郵箱:aikelong@csu.edu.cn歡迎本科生、碩士生、博士生與博士后加入研究團(tuán)隊,要求:做事認(rèn)真,善于溝通,敢想敢干,執(zhí)行力強(qiáng)。

研究領(lǐng)域: 1.  氧化應(yīng)激在心腦血管損傷的機(jī)制研究;

2. 納米藥物在癌癥診療、心腦血管修復(fù)的研究。

教育經(jīng)歷:

1.  武漢大學(xué)  本科

2. 國科大   碩士

3. 吉林大學(xué)  博士

工作經(jīng)歷:

1.  2002.07-201910 中國科學(xué)院長春應(yīng)用化學(xué)研究所,歷任研究實習(xí)員,助理研究員,副研究員

2.  2019.11至今 中南大學(xué)湘雅藥學(xué)院,特聘教授

科研項目:

1. 主持國家自然科學(xué)基金面上項目、青年項目、中南大學(xué)特聘人才科研啟動項目等15項研究課題;

2.  作為核心骨干成員參與科技部國家重點研發(fā)計劃2項、國家自然科學(xué)基金重點項目1項等多個科研課題研究。

獎勵和榮譽(yù):

1.  吉林省自然科學(xué)一等獎(2018,排名第3);

2. 吉林省自然科學(xué)二等獎(2020,排名第3);

3. 吉林省自然科學(xué)一等獎(2012,排名第8);

4. 中國科學(xué)院青年創(chuàng)新促進(jìn)會會員(2014)和優(yōu)秀會員(2019)。

學(xué)術(shù)兼職

1.    中國藥理學(xué)會心血管藥理專業(yè)委員會青年委員會常務(wù)委員;

2.  《分析化學(xué)》青年編委;

3. SmartMat》青年編委;

4.  Military Medical Research》青年編委;

5.  Mini-Reviews in Medicinal Chemistry》編委;

6.  《中南大學(xué)學(xué)報(醫(yī)學(xué)版)》編委;

7.    中國藥理學(xué)會臨床藥學(xué)專業(yè)委員會青年委員會副主任委員;

團(tuán)隊成員成果(新課題組,碩士從2020年招生、博士從2021年開始招生)

1.  趙天嬌,2021級博士,獲周宏灝藥學(xué)優(yōu)秀學(xué)生獎,已在課題組發(fā)表6篇SCI論文IF為20.3,20.722,20.3,17.521,9.7,4.8

2. 王淑雅,2022級博士,湖南省研究生醫(yī)學(xué)創(chuàng)新大賽三等獎,獲威爾曼獎學(xué)金已在課題組發(fā)表SCI論文8篇IF為32.08, 22.5,20.3,17.521,16.6, 16.6, 15.8, 10.269

3.陳俏慧,2023級博士,湖南省研究生醫(yī)學(xué)創(chuàng)新大賽三等獎,獲威爾曼獎學(xué)金,已在課題組發(fā)表10篇SCI論文IF為 33.9, 20.3, 20.3,19, 17.521, 16.744,9.7,6.064,5.988, 5.988

4. 王玨,2024級博士

5.楊詠琪,2022級碩士,獲國家獎學(xué)金, 威爾曼獎學(xué)金已在課題組發(fā)表SCI論文2篇(IF為5.988, 9.7

6.齊維敏,2022級碩士,已在課題組發(fā)表SCI論文1篇(IF為9.7

7. 時肖靜,2022級碩士,已在課題組發(fā)表SCI論文1篇(IF為22.5

8.應(yīng)曉紅2023級碩士,已在課題組發(fā)表SCI論文1篇(IF為33.9

9.  熊廷黎,2023級碩士,已在課題組發(fā)表SCI論文1篇(IF為20.3

10. 黃運(yùn)瑩,2023級碩士

11.張?zhí)N韜,2024級本-博

12.鄭文煊,2024級碩士

13.吳紫宇,2024級碩士

14.夏穎慈,2024級碩士

15.苗晨曦,本-博

已畢業(yè)學(xué)生去向

2023年畢業(yè)

1.  陳俏慧,2020級碩士,湖南省研究生醫(yī)學(xué)創(chuàng)新大賽三等獎,獲威爾曼獎學(xué)金,已在課題組發(fā)表3篇SCI論文IF分別為16.874, 16.744,5.988), 中南大學(xué)攻讀博士,

2.  黃佳,2020級碩士,湖南省自然科學(xué)一等優(yōu)秀學(xué)術(shù)論文,  獲威爾曼獎學(xué)金,已在課題組發(fā)表4篇SCI論文IF分別為17.521,17.521,8.301,5.988),南方科技大學(xué)攻讀博士

3.  陳立,2020級碩士,獲威爾曼獎學(xué)金,已在課題組發(fā)表SCI論文2 (IF分別為11.799,6.025 ) ,澳門大學(xué)攻讀博士

2024年畢業(yè)

4.  肖祚庥,2021級碩士,獲威爾曼獎學(xué)金,中南大學(xué)優(yōu)秀學(xué)生, 湖南省研究生醫(yī)學(xué)創(chuàng)新大賽三等獎,已在課題組發(fā)表2IF分別為16.744,11.6),澳門大學(xué)攻讀博士  

5.  楊禹琪,2021級碩士(聯(lián)培),獲國家獎學(xué)金2次,已在課題組發(fā)表SCI論文5IF分別為17.521,16.874,10.761,15.153, 7) ,香港理工大學(xué)攻讀博士

6.  向羽婷,2021級碩士,獲威爾曼獎學(xué)金, 中南大學(xué)優(yōu)秀學(xué)生,中南大學(xué)優(yōu)秀畢業(yè)生,已在課題組發(fā)表SCI論文3IF分別為19,5.988,5.988), 入職武漢大學(xué)口腔醫(yī)院

7.  龍星余,2021級碩士,獲威爾曼獎學(xué)金, 中南大學(xué)優(yōu)秀學(xué)生,中南大學(xué)優(yōu)秀畢業(yè)生,已在課題組發(fā)表SCI論文2IF分別為32.086,5.988),入職華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院


2025年度

72. Shuya Wang, Yuting Xiang, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Wensheng Chen, Qiaohui Chen, Yongqi Yang, Jue Wang, Qiong Huang*, Kelong Ai*, An eNOS-like nanomaterial for specific reversal of cerebral ischemia-reperfusion injury. Nature Communications, 2025; Just Accepted, IF=16.6

71. Qiaohui Chen, Zuoxiu Xiao, Xiaohong Ying, Yongqi Yang, Jianlin Chen, Ziyu Wu, Wan Zeng, Chenxi Miao, Yayun Nan, Qiong Huang*, Kelong Ai*, Molybdenum-bridged endo-exogenous antioxidant synergy reverses acute kidney injury via mitochondrial homeostasis reconstruction. Bioactive Materials,2025; 54, 777-796. IF=20.2

70. Tingli Xiong?, Shuya Wang?, Xiaojing Shi, Ruishi Li, Wenxuan Zheng, Weimin Qi, Min Liu, Lin Dai, Qiong Huang*, Kelong Ai*, Biomimetic dynamic nanomedicine SrHCF: Lattice self-reconstruction based on Fe2+ response to achieve synergistic “ferrous chelation-antioxidation-calcium antagonism-inflammation inhibition” quadruple treatment of CIRI. Bioactive Materials,2025; Just Accept,  IF=20.2

69.Tianjiao Zhao, Yunying Huang, Wensheng Chen, Weimin Qi, Jue Wang, Yingci Xia, Jia Zhou, Xingyu Long, Yayun Nan, Qiong Huang*, Kelong Ai*, Polydopamine as a Biocompatible and Precise Mitochondrial Targeted Therapeutic Platform for Reversing Myocardial Ischemia-Reperfusion Injury, Bioactive Materials, 2025; Just Accept,  IF=20.2

68. Qian Zeng, Min Liu, Ziqi Wang, Rongrong Zhou*, Kelong Ai*, Enhancing Radiotherapy-induced Anti-tumor Immunity via Nanoparticle-mediated STING Agonist Synergy, Molecular Cancer, 2025; 1-43,  IF=33.9

67. Zerun Liu#, Wensheng Chen#, Jinping Zhang, Ting Huang, Ying Hong, Tianjiao Zhao, Min Liu, Qiaohui Chen, Yongqi Yang, Shuya Wang, Jue Wang, Xiaohong Ying, Yiming Li, Qiong Huang*, Kelong Ai*, UCP2 inhibition eliminates pancreatic β cell autoinflammation in type 2 diabetes mellitus with Islet-mitochondrial sequential targeting nanomeidicnes, Nature Communications, 2025; 16 (1), 6840 IF=16.6

66. Fang Zhao, Zeyu Hu, Gejing Li, Min Liu, Qiong Huang*, Kelong Ai*, Xiong Cai*, Angiogenesis in Rheumatoid Arthritis: Pathological Characterization, Pathogenic Mechanisms, and Nano-targeted Therapeutic Strategies, Bioactive Materials, 2025; 50, 603-639,  IF=20.3

65. Xiaojing Shi#, Shuya Wang#, Tingli Xiong, Ruishi Li, Wenxuan Zheng, Wensheng Chen, Tianjiao Zhao, Yongqi Yang, Xiaohong Ying, Weimin Qi, Yingci Xia, Jue Wang, Qiong Huang*, Kelong Ai*, Specifically breaking through the injured blood-brain barrier with tannic acid-based nanomedicine for ischemic stroke ischemia reperfusion treatment, Exploration, 2025; 0:20240388, IF=22.5

64. Zerun Liu#, Ting Huang#, Ying Hong#, Yuqi Yang, Wensheng Chen, Qingtao Zeng, Qiaohui Chen, Yongqi Yang, Xiaohong Ying, Wan Zeng, Ziyu Wu, Tianjiao Zhao, Xuesi Wan, Jianlin Chen, Kelong Ai*, Qiong Huang*,  Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease, Adv. Sci., 2025; e05168, IF=17.521

63. Dan Wang#, Shuya Wang#, Jinjin Liu, Xiaojing Shi, Tingli Xiong, Ruishi Li, Wei Wei, Liandong Ji, Qiong Huang*, Xuejun Gong*, Kelong Ai*, Nanomedicine Penetrating Blood-Pancreas Barrier for Effective Treatment of Acute Pancreatitis, Adv. Sci., 2025;  https://doi.org/10.1002/advs.202413925, IF=17.521

2024年度

62. Shuya Wang, Xiaojing Shi, Tingli Xiong, Qiaohui Chen, Yongqi Yang, Wensheng Chen, Kexin Zhang, Yayun Nan, Qiong Huang*, Kelong Ai*, Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia-Reperfusion Injury through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue, Adv. Mater., 2024;  2409529,  IF=32.086

61. Xingyu Long#, Min Liu#, Yayun Nan#, Qiaohui Chen, Zuoxiu Xiao, Yuting Xiang, Xiaohong Ying, Jian Sun, Qiong Huang*, Kelong Ai*, Revitalizing Ancient Mitochondria with Nano-strategies: Mitochondria-remedying Nanodrugs Concentrate on Disease Control, Adv. Mater., 2024;  2308239, IF=32.086,高被引

60. Xiaohong Ying#, Qiaohui Chen#, Yongqi Yang, Ziyu Wu, Wan Zeng, Chenxi Miao, Qiong Huang*, Kelong Ai*, Nanomedicines Harnessing cGAS-STING Pathway: Sparking Immune Revitalization to Transform 'Cold' Tumors into 'Hot' Tumors, Molecular Cancer, 2024; 23, 277.  IF=33.9

59. Chuang Yuan#, Qicai Xiao#, Qiaohui Chen, Qiong Huang, Kelong Ai*, Xinyu Yang*, Anticoagulant Therapy without Bleeding: A Novel Molybdenum-based Nanodots Alleviate Lethal Coagulation in Bacterial Sepsis by Inhibiting ROS-facilitated Caspase-11 Activation, SmartMat, 2024; e1264,  IF=20.4

58. Yuting Xiang#, Qiaohui Chen#, Yayun Nan#, Min Liu, Zuoxiu Xiao, Yuqi Yang, Jinping Zhang, Xiaohong Ying, Xingyu Long, Shuya Wang, Jian Sun, Qiong Huang*, Kelong Ai*, Nitric Oxide-Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment, Adv. Functional Mater., 2024; 2312092,  IF=19.924

57. Yamei Liu#, Shuya Wang#, Jiaxiong Zhang, Quan Sun , Yi Xiao , Jing Chen , Meilian Yao, Guogang Zhang, Qun Huang, Tianjiao Zhao, Qiong Huang, Xiaojing Shi , Can Feng, Jian Sun, Kelong Ai*, Yongping Bai*, Reprogramming the Myocardial Infarction Microenvironment with Melanin Composite Nanomedicine,  Nat. Commun., 2024;  15, 6651.  IF=16.6

56. Jiaxiong Zhang#, Shuya Wang#, Quan Sun, Jian Zhang, Xiaojing Shi, Meilian Yao, Jing Chen, Qiong Huang, Guogang Zhang, Qun Huang, Kelong Ai*, Yongping Bai*, ONOO- free NO-embedded Nanoparticle (OFEN) Maintains NO Homeostasis for Effective Revascularization of Myocardial Infarcts, ACS Nano, 2024; 18, 32650,  IF=16

55. Qiaohui Chen, Yongqi Yang, Xiaohong Ying, Changkun Huang, Jianlin Chen, Jue Wang, Ziyu Wu, Wan Zeng, Chenxi Miao, Xiaojing Shi, Qiong Huang*, Kelong Ai*, Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury, Adv. Sci., 2024; 2411254, IF=17.521

2023年度

54. Mingyuan Wang#, Qiong Huang#, Min Liu, Tianjiao Zhao, Xiangping Song, Qiaohui Chen, Yongqi Yang, Yayun Nan, Zerun Liu, Yuntao Zhang, Wei Wu*, Kelong Ai*, Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin-α Embedded Nanomedicine (OPEN), Adv. Mater., 2023; 35(49),  2309370, IF=32.086

53. Xiangping Song#, Qiong Huang#, Yuqi Yang, Liang Ma, Wenguang Liu, Chunlin Ou, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Mingyuan Wang, Yitian Jiang, Yunrong Yang, Jinping Zhang, Yayun Nan, Wei Wu*, Kelong Ai*, Efficient Therapy of Inflammatory Bowel Disease (IBD) with Highly Specific and Durable Targeted Ta2C Modified with Chondroitin Sulfate (TACS), Adv. Mater., 2023; 35(36), 2301585, IF=32.086

52. Qiong Huang, Yuqi Yang, Tianjiao Zhao, Qiaohui Chen, Min Liu, Shuting Ji, Yan Zhu, Yunrong Yang, Jinping Zhang, Haixin Zhao, Yayun Nan, Kelong Ai*, Passively-targeted Mitochondrial Tungsten-based Nanodots for Efficient Acute Kidney Injury Treatment. Bioactive Materials. 2023,21,381-393. IF=20.3,高被引

51. Qiaohui Chen#, Yayun Nan#, Yuqi Yang, Zuoxiu Xiao, Min Liu, Jia Huang, Yuting Xiang, Xingyu Long, Tianjiao Zhao, Xiaoyuan Wang, Qiong Huang*, Kelong Ai*. Nanodrugs Alleviate Acute Kidney Injury: Manipulate RONS at Kidney. Bioactive Materials. 2023, 22, 141-167.  IF=20.3,高被引,熱點論文

50. Jia Huang#, Guiming Deng#, Shuya Wang, Tianjiao Zhao, Qiaohui Chen, Yuqi Yang, Yongqi Yang, Jinping Zhang, Yayun, Nan, Zhaoqian Liu, Ke Cao, Qiong Huang*, Kelong Ai*, A NIR-II Photoactivatable “ROS Bomb” with High-density Cu2O-supported MoS2 Nanoflowers for Anticancer Therapy, Adv. Sci., 2023, 10(24), 2302208. IF=17.521

49. Qiong Huang, Zerun Liu, Yunrong Yang, Yuqi Yang, Ting Huang, Ying Hong, Jinping Zhang, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Xuejun Gong, Yitian Jiang, Jiang Peng, Yayun Nan, Kelong Ai*, Selenium nanodots (SENDs) as antioxidants and antioxidant-prodrugs to rescue islet β cells in type 2 diabetes mellitus by restoring mitophagy and alleviating endoplasmic reticulum stress, Adv. Sci., 2023, 10(19), 2300880. IF=17.521

48. Quan Sun, Hongqin Ma, Jiaxiong Zhang, Baiyang You, Xiaohui Gong, Xiaolin Zhou, Jin Chen, Guogang Zhang, Jia Huang, Qiong Huang, Yurong Yang, Kelong Ai*, Yongping Bai*, A Self-Sustaining Antioxidant Strategy for Effective Treatment of Myocardial Infarction. Adv. Sci., 2023, 10(5), 2204999. IF=17.521

47. Yunrong Yang#, Jia Huang#, Min Liu, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Yuqi Yang, Qiong Huang*, Kelong Ai*, Emerging Sonodynamic Therapy-based Nanomedicines for Cancer Immunotherapy, Adv. Sci., 2023, 10(2), 2204365, IF=17.521

46. Qiong Huang, Yuqi Yang, Yan Zhu, Qiaohui Chen, Tianjiao Zhao, Zuoxiu Xiao, Mingyuan Wang, Xiangping Song, Yitian Jiang, Yunrong Yang, Jinping Zhang, Yang Xiao, Yayun Nan, Wei Wu*, Kelong Ai*, Oral Metal-free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD), Small, 2023, 19(19), 2207350, IF=15.153

45. Hong Liu, Shuya Wang, Qiaohui Chen, Xiaoyue Ge, Huang Ning, Yanzi Guo, Di Wang, Kelong Ai*, Changping Hu*, Natural Targeting Potent ROS-eliminating Tungsten-based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension, Adv. Healthcare Mater., 2023, 12(22),  202300252, IF=11.092

44.  Shuya Wang, Qiaohui Chen. Tianjiao Zhao, Kelong Ai*, Changping Hu*, Nanomedicine-based treatment: an emerging therapeutical strategy for pulmonary hypertension, Nano Research, 2023, 16(5), 4007-7029, IF=10.269

43. Haixin Zhao, Jia Huang, Lulu Huang, Yuqi Yang, Zuoxiu Xiao, Qiaohui Chen, Qiong Huang*, Kelong Ai*. Surface control approach for growth of cerium oxide on flower-like molybdenum disulfide nanosheets enables superior removal of uremic toxins. Journal of Colloid and Interface Science, 2023, 630, 855-865. IF=9.965

42.Yuqi Yang#, Yayun Nan#, Zuoxiu Xiao, Yuntao Zhang, Huanan Zhang,  Qiong Huang*, Kelong Ai*, Antioxidative 0-dimensional Nanodrugs Overcomes Obstacles in AKI Antioxidant Therapy, Journal of Materials Chemistry B, 2023, 11(34), 8081-8095. IF=7

41. Qiaohui Chen#, Xiaoyuan Wang#, Chao Yuan#, Yayun Nan*, Qiong Huang*, Kelong Ai*. 2D-nanomaterials for AKI treatment, Frontiers in Bioengineering and Biotechnology, 2023, 11, 1159989. IF=6.064


2022年度

40. Yan Zhu#, Tianjiao Zhao#, Min Liu, Shuya Wang, Saili Liu, Yunrong Yang, Yuqi Yang, Yayun Nan, Qiong Huang*, Kelong Ai*.  Rheumatoid Arthritis Microenvironment Insights into Treatment Effect of Nanomaterials. Nano Today. 2022; 42, 101358. IF=20.722  高被引

39. Zhao Tianjiao#, Wu Wei#, Sui Lihua, Huang Qiong*, Nan Yayun, Liu Jianhua, Ai Kelong*. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioactive Materials. 2022; 7, 47-72. IF=20.3 高被引,熱點論文

38. Yuqi Yang#, Tianjiao Zhao#, Qiaohui Chen, Yumei Li, Zuoxiu Xiao, Yuting Xiang, Boyu Wang, Yige Qiu, Shiqi Tu, Yitian Jiang, Yayun Nan, Qiong Huang*, Kelong Ai*, Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC, Adv. Sci., 2022; 2202797, IF=17.521

37. Haixin Zhao, Jia Huang, Lu Miao, Yuqi Yang, Zuoxiu Xiao, Qiaohui Chen, Qiong Huang*, Kelong Ai*, Toward Urease-Free Wearable Artificial Kidney: Widened Interlayer Spacing MoS2 Nanosheets with Highly Effective Adsorption for Uremic Toxins. Chemical. Engineering Journal, 2022, 438, 135583. IF=16.744

36. Zuoxiu Xiao#, Qiaohui Chen#, Yuqi Yang, Shiqi Tu, Boyu Wang, Yige Qiu, Yitian Jiang, Qiong Huang*, Kelong Ai*,  Chemical. Engineering Journal, 2022; 137889, IF=16.744

35. Min Liu, Yuting Xiang, Yuqi Yang, Xingyu Long, Zuoxiu Xiao, Yayun Nan,Yige Qiu, Yitian Jiang, Qiong Huang*, Kelong Ai*, Biosensors and Bioelectronics, 2022;114758, IF=12.6

34. Zuoxiu Xiao, Qiong Huang, Yuqi Yang, Min Liu, Qiaohui Chen, Jia Huang, Yuting Xiang, Xingyu Long, Tianjiao Zhao, Xiaoyuan Wang, Xiaoyu Zhu, Shiqi Tu, Yayun Nan, Kelong Ai*, Emerging early diagnostic methods for acute kidney injury. Theranostics, 2022, 12(6): 2963-2986. IF=12.4

33. Min Liu, Qiong Huang, Yan Zhu, Li Chen, Yumei Li, Zhicheng Gong*, Kelong Ai*, Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio. 2022, 13, 100218. IF=10.761 高被引

32. Yuqi Yang, Qiong Huang, Zuoxiu Xiao, Min Liu, Yan Zhu, Qiaohui Chen, Yumei Li, Kelong Ai*, Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer. Materials Today Bio. 2022, 13, 100218. IF=10.761

31. Yuan, Chuang#; Ai, Kelong#; Xiang, Menghua; Xie, Chengliang; Zhao, Mingyi; Wu, Ming; Li, Hongli; Wu, Yueren; Cao, Yueqing; Li, Can; Zhong, Yanjun; Pei, Xiaomeng; Law, Helen Ka Wai; Gao, Liqian; Xiao, Qicai*; Yang, Xinyu*, Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling. Cell Death & Disease, 2022, 13(8), 722. IF=9.685

30. Jia Huang, Qiong Huang, Min Liu, Qiaohui Chen, Kelong Ai*, Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy. Frontiers in Pharmacology, 2022, 13, 844037. IF=5.81 高被引


2021年度

29. Wang Jianling#, Sui Lihua#, Huang Jia, Miao Lu, Nie Yubing, Wang Kuansong, Yang Zhichun*, Huang Qiong, Gong Xue, Nan Yayun, Ai Kelong*. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioactive Materials. 2021; 6(11): 4209-4242. IF=20.3 高被引,熱點論文,Bioactive Materials-Best Paper Award 2021

28. Chen Li#, Huang Qiong#, Zhao Tianjiao, Sui Lihua, Wang Shuya, Xiao Zuoxiu, Nan Yayun, Ai Kelong*. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19. Redox Biology. 2021; 45: 102046-102046. IF=11.799

27. Li Zelun#, Wang Juan#, Chen Qian, Ai Kelong*, Lu Lehui*. Hierarchically porous polymer with ultra-high affinity for bisphenol A enables high efficient water purification. Science China Chemistry. 2021. IF=10.138

26. Kelong Ai, Jia Huang, Zuoxiu Xiao, Yuqi Yang, Yuwang Bai, Jun Peng*. Localized surface plasmon resonance properties and biomedical applications of copper selenide nanomaterials. Materials Today Chemistry. 2021; 8:100402. IF=8.301


2020年度

25. Yu Bin, Ai Kelong*, Lu Lehui*. Dual-protective nano-sunscreen enables high-efficient elimination of the self-derived hazards. Applied Materials Today. 2020; 18. IF=10.041

24. Sui Lihua#, Wang Jianling#, Xiao Zuoxiu, Yang Yuqi, Yang Zhichun*, Ai Kelong*. ROS-Scavenging Nanomaterials to Treat Periodontitis. Frontiers in Chemistry. 2020; 8. IF=5.221

23. Li Niansheng, Chen Li, Xiao Zuoxiu, Yang Yuqi, Ai Kelong*. Progress in Detection of Biomarker of Ovarian Cancer: Lysophosphatidic Acid. Chinese Journal of Analytical Chemistry. 2020; 48(12): 1597-1606. IF=1.134

22. Huang Qiong, Wu Wei*, Ai Kelong*, Liu Jianhua. Highly Sensitive Polydiacetylene Ensembles for Biosensing and Bioimaging. Frontiers in Chemistry. 2020; 8. IF=5.221


2019年以前

21. Wang Juan, Li Zelun, Wang Ying, Wei Changting, Ai Kelong*, Lu Lehui*. Hydrogen bond-mediated strong adsorbent-I3- interactions enable high-efficiency radioiodine capture. Materials Horizons. 2019; 6(7): 1517-1525. IF=15.717

20. Wang Juan, Ai Kelong*, Lu Lehui*. Flame-retardant porous hexagonal boron nitride for safe and effective radioactive iodine capture. Journal of Materials Chemistry A. 2019; 7(28): 16850-16858. IF=14.511

19. Li Zelun, Chang Xuling, Wang Ying, Wei Changting, Wang Juan, Ai Kelong*, Zhang Ye*, Lu Lehui*. Point-and-Shoot Strategy for Identification of Alcoholic Beverages. Analytical Chemistry. 2018; 90(16): 9838-9844. IF=8.008

18. Ai Kelong, Li Zelun, Li Weiwei, Fan Jinchang, Cui Xiaoqiang*, Zheng Weitao. Robust Synthesis of High-Performance N-Graphite Hollow Nanocatalysts Based on the Ostwald Ripening Mechanism for Oxygen Reduction Reaction Electrocatalysis. Particle & Particle Systems Characterization. 2018; 35(10). IF=3.310

17. Wang Ying, Pei Hanwen, Jia Yan, Liu Jianhua, Li Zelun, Ai Kelong*, Lu Zhongyuan, Lu Lehui*. Synergistic Tailoring of Electrostatic and Hydrophobic Interactions for Rapid and Specific Recognition of Lysophosphatidic Acid, an Early-Stage Ovarian Cancer Biomarker. Journal of the American Chemical Society. 2017; 139(33): 11616-11621. IF=16.383

16. Liu Yanlan#, Ai Kelong#, Ji Xiaoyuan, Askhatova Diana, Du Rose, Lu Lehui*, Shi Jinjun*. Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke. Journal of the American Chemical Society. 2017; 139(2): 856-862. IF=16.383

15. Li Zelun#, Ai Kelong#, Yang Zhe, Zhang Tianqi, Liu Jianhua, Cui Xiaoqiang*. Untrasmall Bi2S3 nanodots for in vivo X-ray CT imaging-guided photothermal therapy of cancer. RSC Advances. 2017; 7(47): 29672-29678. IF=4.036

14. Ai Kelong, Li Zelun, Cui Xiaoqiang*. Scalable preparation of sized-controlled Co-N-C electrocatalyst for efficient oxygen reduction reaction. Journal of Power Sources. 2017; 368: 46-56. IF=9.794

13. Ruan Changping, Shen Mengxia, Ren Xiaoyan, Ai Kelong*, Lu Lehui*. A Versatile and Scalable Approach toward Robust Superhydrophobic Porous Materials with Excellent Absorbency and Flame Retardancy. Scientific Reports. 2016; 6. IF=4.379

12. Ai Kelong, Ruan Changping, Shen Mengxia, Lu Lehui*. MoS2 Nanosheets with Widened Interlayer Spacing for High-Efficiency Removal of Mercury in Aquatic Systems. Advanced Functional Materials. 2016; 26(30): 5542-5549. IF=19.924

11. Shen Mengxia, Zheng Li-Rong, He Wenhui, Ruan Changping, Jiang Chunhuan, Ai Kelong*, Lu Lehui*. High-performance oxygen reduction electrocatalysts derived from uniform cobalt-adenine assemblies. Nano Energy. 2015; 17: 120-130. IF=19.096

10. Shen Mengxia, Ruan Changping, Chen Yan, Jiang Chunhuan, Ai Kelong*, Lu Lehui*. Covalent Entrapment of Cobalt-Iron Sulfides in N-Doped Mesoporous Carbon: Extraordinary Bifunctional Electrocatalysts for Oxygen Reduction and Evolution Reactions. ACS Applied Materials & Interfaces. 2015; 7(2): 1207-1218. IF=10.383

9. He Wenya, Ai Kelong*, Lu Lehui. Nanoparticulate X-ray CT contrast agents. Science China-Chemistry. 2015; 58(5): 753-760. IF=10.138

8. Ruan Changping#, Ai Kelong#, Li Xingbo, Lu Lehui*. A Superhydrophobic Sponge with Excellent Absorbency and Flame Retardancy. Angewandte Chemie-International Edition. 2014; 53(22): 5556-5560. IF=16.823

7. Liu Yanlan#, Ai Kelong#, Liu Jianhua, Deng Mo, He Yangyang, Lu Lehui*. Dopamine-Melanin Colloidal Nanospheres: An Efficient Near-Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy. Advanced Materials. 2013; 25(9): 1353-1359. IF=32.086

6. Li Meili, Sun Guoying*, Yin Pingping, Ruan Changping, Ai Kelong*. Controlling the Formation of Rodlike V2O5 Nanocrystals on Reduced Graphene Oxide for High-Performance Supercapacitors. ACS Applied Materials & Interfaces. 2013; 5(21): 11462-11470. IF=10.383

5. Ai Kelong#, Liu Yanlan#, Ruan Changping, Lu Lehui*, Lu Gaoqing*. Sp2 C-Dominant N-Doped Carbon Sub-micrometer Spheres with a Tunable Size: A Versatile Platform for Highly Efficient Oxygen-Reduction Catalysts. Advanced Materials. 2013; 25(7): 998-1003. IF=32.086

4. Ai Kelong, Liu Yanlan, Lu Lehui*, Cheng Xiaoli, Huo Lihua. A novel strategy for making soluble reduced graphene oxide sheets cheaply by adopting an endogenous reducing agent. Journal of Materials Chemistry. 2011; 21(10): 3365-3370. IF=12.732

3. Ai Kelong, Liu Yanlan, Liu Jianhua, Yuan Qinghai, He Yangyang, Lu Lehui*. Large-Scale Synthesis of Bi2S3 Nanodots as a Contrast Agent for In Vivo X-ray Computed Tomography Imaging. Advanced Materials. 2011; 23(42): 4886-4891. IF=32.086

2. Ai Kelong, Zhang Baohua, Lu Lehui*. Europium-Based Fluorescence Nanoparticle Sensor for Rapid and Ultrasensitive Detection of an Anthrax Biomarker. Angewandte Chemie-International Edition. 2009; 48(2): 304-308. IF=16.823

1. Ai Kelong, Liu Yanlan, Lu Lehui*. Hydrogen-Bonding Recognition-Induced Color Change of Gold Nanoparticles for Visual Detection of Melamine in Raw Milk and Infant Formula. Journal of the American Chemical Society. 2009; 131(27): 9496. IF=16.383



上一條:鄧旭 教授

下一條:陳飛 副研究員

马关县| 灵石县| 阳朔县| 离岛区| 渭源县| 海城市| 武城县| 饶河县| 安阳县| 湖南省| 乳源| 安陆市| 盐山县| 广丰县| 永登县| 丰原市| 高要市| 于都县| 同江市| 新巴尔虎左旗| 仁化县| 徐闻县| 遵义市| 龙岩市| 伊通| 辽宁省| 历史| 永新县| 闽清县| 星子县| 麻城市| 通辽市| 吴江市| 凉城县| 江津市| 寿阳县| 雅安市| 那坡县| 汶上县| 巴彦淖尔市| 买车|